Antibody and cellular responses to HIV vaccine regimens with DNA plasmid as compared with ALVAC priming: An analysis of two randomized controlled trials.

MLA

Zoe Moodie, et al. “Antibody and Cellular Responses to HIV Vaccine Regimens with DNA Plasmid as Compared with ALVAC Priming: An Analysis of Two Randomized Controlled Trials.” PLoS Medicine, vol. 17, no. 5, May 2020, p. e1003117. EBSCOhost, https://doi.org/10.1371/journal.pmed.1003117.

APA

Zoe Moodie, Stephen R Walsh, Fatima Laher, Lucas Maganga, Michael E Herce, Sarita Naidoo, Mina C Hosseinipour, Craig Innes, Linda-Gail Bekker, Nicole Grunenberg, Philipp Mann, Chenchen Yu, Allan C deCamp, Maurine D Miner, Nicole L Yates, Jack Heptinstall, Nonhlanhla N Mkhize, One Dintwe, Nicole Frahm, … NIAID HVTN 100 and HVTN 111 trial teams. (2020). Antibody and cellular responses to HIV vaccine regimens with DNA plasmid as compared with ALVAC priming: An analysis of two randomized controlled trials. PLoS Medicine, 17(5), e1003117. https://doi.org/10.1371/journal.pmed.1003117

Chicago

Zoe Moodie, Stephen R Walsh, Fatima Laher, Lucas Maganga, Michael E Herce, Sarita Naidoo, Mina C Hosseinipour, et al. 2020. “Antibody and Cellular Responses to HIV Vaccine Regimens with DNA Plasmid as Compared with ALVAC Priming: An Analysis of Two Randomized Controlled Trials.” PLoS Medicine 17 (5): e1003117. doi:10.1371/journal.pmed.1003117.